Emany Sravan Kumar

Assertio Holdings, Inc. · Director

Emany Sravan Kumar is listed in filings as Director at Assertio Holdings, Inc.. This profile follows SEC Form 4 activity through May 6, 2026, including sale activity. Recent filings connect the profile to Assertio Holdings, Inc. (ASRT), Beam Therapeutics Inc. (BEAM), Kyverna Therapeutics, Inc. (KYTX), and Ironwood Pharmaceuticals, Inc. (IRWD). The current snapshot covers public activity from Nov 20, 2024 to May 6, 2026. Reported amounts are shown as $341.4K to $170.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Latest Trades

CompanyValueActionPriceLast Price
Beam Therapeutics Inc.BEAM$171k6.3k sharesSellDec 31, 2025$27.10$30.84